Calcium and magnesium nutrition in human hypertension - PubMed (original) (raw)
Calcium and magnesium nutrition in human hypertension
D A McCarron. Ann Intern Med. 1983 May.
Abstract
Many studies suggest that reduced consumption of calcium or magnesium is associated with an increased risk of developing hypertension and cardiovascular disease. Results of animal studies show that restriction of calcium increases, and supplementation with calcium lowers, the blood pressure of normal and hypertensive rats. Data from the Health and Nutrition Examination Survey I done by the National Center for Health Statistics document the relation between dietary calcium intake and the risk of hypertension in the United States. Hypertensive persons consumed 18% less dietary calcium (hypertensive, 572 +/- 17 mg, versus normotensive, 695 +/- 7 mg; p less than 0.0001). Of the 17 nutrients analyzed, only calcium distinguished hypertensive persons from normotensive persons in all subgroups. Of all nutritional factors assessed, reduced consumption of calcium most consistently distinguishes hypertensive persons from normotensive persons.
Similar articles
- Dietary calcium and magnesium supplements in spontaneously hypertensive rats and isolated arterial reactivity.
Mäkynen H, Kähönen M, Arvola P, Wuorela H, Vapaatalo H, Pörsti I. Mäkynen H, et al. Br J Pharmacol. 1995 Aug;115(8):1455-62. doi: 10.1111/j.1476-5381.1995.tb16637.x. Br J Pharmacol. 1995. PMID: 8564205 Free PMC article. - Lifestyle modifications to prevent and control hypertension. 6. Recommendations on potassium, magnesium and calcium. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
Burgess E, Lewanczuk R, Bolli P, Chockalingam A, Cutler H, Taylor G, Hamet P. Burgess E, et al. CMAJ. 1999 May 4;160(9 Suppl):S35-45. CMAJ. 1999. PMID: 10333852 Free PMC article. - Relationship between diet and blood pressure in a representative Mediterranean population.
Schröder H, Schmelz E, Marrugat J. Schröder H, et al. Eur J Nutr. 2002 Aug;41(4):161-7. doi: 10.1007/s00394-002-0372-4. Eur J Nutr. 2002. PMID: 12242584 - Calcium supplementation in the treatment of hypertension.
Mercola J. Mercola J. J Am Osteopath Assoc. 1985 Jun;85(6):383-6. J Am Osteopath Assoc. 1985. PMID: 3905729 Review. No abstract available. - Clinical aspects of parathyroid hypertensive factor.
Lewanczuk RZ, Benishin CG, Shan J, Pang PK. Lewanczuk RZ, et al. J Cardiovasc Pharmacol. 1994;23 Suppl 2:S23-6. J Cardiovasc Pharmacol. 1994. PMID: 7518541 Review.
Cited by
- Diet modification for treatment and prevention of obesity.
Ness-Abramof R, Apovian CM. Ness-Abramof R, et al. Endocrine. 2006 Feb;29(1):5-9. doi: 10.1385/endo:29:1:5. Endocrine. 2006. PMID: 16622287 Review. - Magnesium deficiency. Causes and clinical implications.
Whang R. Whang R. Drugs. 1984 Oct;28 Suppl 1:143-50. doi: 10.2165/00003495-198400281-00014. Drugs. 1984. PMID: 6499696 - Influence of calcium and vitamin D supplementation on weight and fat loss in obese women.
Holecki M, Zahorska-Markiewicz B, Wiecek A, Mizia-Stec K, Nieszporek T, Zak-Gołab A. Holecki M, et al. Obes Facts. 2008;1(5):274-9. doi: 10.1159/000169831. Epub 2008 Oct 23. Obes Facts. 2008. PMID: 20054189 Free PMC article. Clinical Trial. - Magnesium and the anaesthetist.
Gambling DR, Birmingham CL, Jenkins LC. Gambling DR, et al. Can J Anaesth. 1988 Nov;35(6):644-54. doi: 10.1007/BF03020356. Can J Anaesth. 1988. PMID: 3060283 Review. - Chronic low-level lead exposure. Its role in the pathogenesis of hypertension.
Sharp DS, Becker CE, Smith AH. Sharp DS, et al. Med Toxicol. 1987 May-Jun;2(3):210-32. doi: 10.1007/BF03259865. Med Toxicol. 1987. PMID: 3298924 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical